Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000558.5(HBA1):c.397G>A (p.Val133Met)	HBA1|LOC106804613	V133M	not provided	Likely benign(Last reviewed: Aug 19, 2022)	criteria provided, single submitter	VCV002428618	16	227378	16	177379	2428618	2402060		NC_000016.10:177378:G:A
NM_000558.5(HBA1):c.296T>A (p.Phe99Tyr)	HBA1|LOC106804613	F99Y	Inborn genetic diseases	Uncertain significance(Last reviewed: Dec 3, 2021)	criteria provided, single submitter	VCV002263512	16	227128	16	177129	2263512	2249031		NC_000016.10:177128:T:A
NM_000558.5(HBA1):c.264C>G (p.His88Gln)	HBA1|LOC106804613	H88Q	not provided	Likely pathogenic(Last reviewed: May 19, 2022)	criteria provided, single submitter	VCV001809522	16	227096	16	177097	1809522	1866526		NC_000016.10:177096:C:G
NM_000558.5(HBA1):c.186G>T (p.Lys62Asn)	HBA1|LOC106804613	K62N	not provided	Uncertain significance(Last reviewed: Dec 10, 2020)	criteria provided, single submitter	VCV001330840	16	227018	16	177019	1330840	1321518		NC_000016.10:177018:G:T
NM_000558.5(HBA1):c.98T>A (p.Met33Lys)	HBA1|LOC106804613	M33K	not provided	Pathogenic(Last reviewed: Mar 26, 2021)	criteria provided, single submitter	VCV001330794	16	226930	16	176931	1330794	1321472		NC_000016.10:176930:T:A
NM_000558.5(HBA1):c.309C>A (p.Ser103Arg)	HBA1|LOC106804613	S103R	not provided	Likely benign(Last reviewed: Jun 15, 2021)	criteria provided, single submitter	VCV001330740	16	227290	16	177291	1330740	1321418		NC_000016.10:177290:C:A
NM_000558.5(HBA1):c.326C>A (p.Thr109Asn)	HBA1|LOC106804613	T109N	not provided	Likely pathogenic(Last reviewed: Mar 4, 2021)	criteria provided, single submitter	VCV001330688	16	227307	16	177308	1330688	1321366		NC_000016.10:177307:C:A
NM_000558.5(HBA1):c.256G>C (p.Asp86His)	HBA1|LOC106804613	D86H	not provided	Uncertain significance(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000994421	16	227088	16	177089	994421	981946	rs33915947	NC_000016.10:177088:G:C
NM_000558.5(HBA1):c.416C>G (p.Ser139Cys)	HBA1|LOC106804613	S139C	not provided	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000993935	16	227397	16	177398	993935	981951	rs63749989	NC_000016.10:177397:C:G
NM_000558.5(HBA1):c.19G>C (p.Asp7His)	HBA1|LOC106804613	D7H	not provided	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000993656	16	226734	16	176735	993656	981943	rs33961916	NC_000016.10:176734:G:C
NM_000558.5(HBA1):c.178G>C (p.Gly60Arg)	HBA1|LOC106804613	G60R	not provided	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000993066	16	227010	16	177011	993066	981144	rs281864895	NC_000016.10:177010:G:C
NM_000558.5(HBA1):c.257A>T (p.Asp86Val)	HBA1|LOC106804613	D86V	alpha Thalassemia	Uncertain significance(Last reviewed: Aug 15, 2020)	no assertion criteria provided	VCV000990364	16	227089	16	177090	990364	979761	rs1902160217	NC_000016.10:177089:A:T
NM_000558.5(HBA1):c.2T>G (p.Met1Arg)	HBA1|LOC106804613	M1R	alpha Thalassemia	Pathogenic(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV000915293	16	226717	16	176718	915293	903608	rs1316527998	NC_000016.10:176717:T:G
NM_000558.5(HBA1):c.63C>A (p.His21Gln)	HBA1|LOC106804613	H21Q	not provided	Likely benign(Last reviewed: Oct 11, 2021)	criteria provided, single submitter	VCV000811635	16	226778	16	176779	811635	799852	rs281864502	NC_000016.10:176778:C:A
NM_000558.5(HBA1):c.413C>T (p.Thr138Ile)	HBA1|LOC106804613	T138I	not provided	Uncertain significance(Last reviewed: Mar 31, 2019)	criteria provided, single submitter	VCV000801166	16	227394	16	177395	801166	789598	rs1596574446	NC_000016.10:177394:C:T
NM_000558.5(HBA1):c.365T>A (p.Val122Glu)	HBA1|LOC106804613	V122E	not provided	Uncertain significance(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000801165	16	227346	16	177347	801165	789597	rs775764044	NC_000016.10:177346:T:A
NM_000558.5(HBA1):c.335C>T (p.Ala112Val)	HBA1|LOC106804613	A112V	not provided	Likely benign(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000801164	16	227316	16	177317	801164	789596	rs1596574253	NC_000016.10:177316:C:T
NM_000558.5(HBA1):c.146T>C (p.Leu49Pro)	HBA1|LOC106804613	L49P	not provided	Uncertain significance(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000801162	16	226978	16	176979	801162	789594	rs281864480	NC_000016.10:176978:T:C
NM_000558.5(HBA1):c.55G>A (p.Gly19Ser)	HBA1|LOC106804613	G19S	not provided	Uncertain significance(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000619845	16	226770	16	176771	619845	611279	rs34504387	NC_000016.10:176770:G:A
NM_000558.5(HBA1):c.178G>A (p.Gly60Ser)	HBA1|LOC106804613	G60S	not provided	Uncertain significance(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000619840	16	227010	16	177011	619840	611274	rs281864895	NC_000016.10:177010:G:A
NM_000558.5(HBA1):c.47G>A (p.Gly16Asp)	HBA1|LOC106804613	G16D	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2021)	criteria provided, conflicting interpretations	VCV000618155	16	226762	16	176763	618155	609949	rs281865560	NC_000016.10:176762:G:A
NM_000517.6(HBA2):c.369C>G (p.His123Gln)	HBA1|HBA2|LOC106804612	H123Q	not provided|Heinz body anemia|Erythrocytosis, familial, 7|Heinz body anemia|alpha Thalassemia|Hemoglobin H disease|Erythrocytosis, familial, 7|alpha Thalassemia|Hemoglobin H disease	Conflicting interpretations of pathogenicity(Last reviewed: Nov 29, 2022)	criteria provided, conflicting interpretations	VCV000439771	16	223539	16	173540	439771	433152	rs41479347	NC_000016.10:173539:C:G
NM_000558.5(HBA1):c.43T>C (p.Trp15Arg)	HBA1|LOC106804613	W15R	not provided	Pathogenic(Last reviewed: Dec 29, 2020)	criteria provided, single submitter	VCV000439103	16	226758	16	176759	439103	432865	rs33964317	NC_000016.10:176758:T:C
NM_000558.5(HBA1):c.332C>T (p.Ala111Val)	HBA1|LOC106804613	A111V	not specified	Uncertain significance(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000439099	16	227313	16	177314	439099	432870	rs63749948	NC_000016.10:177313:C:T
NM_000558.5(HBA1):c.207C>A (p.Asn69Lys)	HBA1|LOC106804613	N69K	alpha Thalassemia	not provided	no assertion provided	VCV000375748	16	227039	16	177040	375748	362634	rs1060339	NC_000016.10:177039:C:A
NM_000558.3(HBA1):c.239C>G (p.Ala80Gly)	HBA1|LOC106804613	A80G		no interpretation for the single variant	no interpretation for the single variant	VCV000242709	16	227071	16	177072	242709	38474	rs387906544	NC_000016.10:177071:C:G
NM_000558.5(HBA1):c.262C>A (p.His88Asn)	HBA1|LOC106804613	H88N	HEMOGLOBIN AUCKLAND	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015893	16	227094	16	177095	15893	30932	rs28928876	NC_000016.10:177094:C:A
NM_000558.3(HBA1):c.313T>A (p.Cys105Ser)	HBA1|LOC106804613	C105S	HEMOGLOBIN OEGSTGEEST	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015890	16	227294	16	177295	15890	30929	rs35059618	NC_000016.10:177294:T:A
NM_000558.3(HBA1):c.154G>A (p.Gly52Ser)	HBA1|LOC106804613	G52S	not provided	Likely benign(Last reviewed: Sep 20, 2022)	criteria provided, single submitter	VCV000015889	16	226986	16	176987	15889	30928	rs33960522	NC_000016.10:176986:G:A
NM_000558.3(HBA1):c.269A>G (p.His90Arg)	HBA1|LOC106804613	H90R	HEMOGLOBIN TAMANO	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015888	16	227101	16	177102	15888	30927	rs33944813	NC_000016.10:177101:A:G
NM_000558.3(HBA1):c.269A>C (p.His90Pro)	HBA1|LOC106804613	H90P	HEMOGLOBIN TOKYO	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015887	16	227101	16	177102	15887	30926	rs33944813	NC_000016.10:177101:A:C
NM_000558.3(HBA1):c.268C>T (p.His90Tyr)	HBA1|LOC106804613	H90Y	HEMOGLOBIN VILLEURBANNE	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015886	16	227100	16	177101	15886	30925	rs34988734	NC_000016.10:177100:C:T
NM_000558.3(HBA1):c.270C>G (p.His90Gln)	HBA1|LOC106804613	H90Q	not provided	Likely benign(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV000015885	16	227102	16	177103	15885	30924	rs1061009	NC_000016.10:177102:C:G
NM_000558.5(HBA1):c.300G>T (p.Lys100Asn)	HBA1|LOC106804613	K100N	HEMOGLOBIN BEZIERS	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015884	16	227132	16	177133	15884	30923	rs34273731	NC_000016.10:177132:G:T
NM_000558.3(HBA1):c.281T>C (p.Val94Ala)	HBA1|LOC106804613	V94A	HEMOGLOBIN DIE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015883	16	227113	16	177114	15883	30922	rs34769782	NC_000016.10:177113:T:C
NM_000558.3(HBA1):c.123G>C (p.Lys41Asn)	HBA1|LOC106804613	K41N	HEMOGLOBIN SARATOGA SPRINGS	other(Last reviewed: May 21, 2018)	no assertion criteria provided	VCV000015882	16	226955	16	176956	15882	30921	rs28928886	NC_000016.10:176955:G:C
NM_000558.3(HBA1):c.30C>G (p.Asn10Lys)	HBA1|LOC106804613	N10K	HEMOGLOBIN DELFZICHT	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015881	16	226745	16	176746	15881	30920	rs28928885	NC_000016.10:176745:C:G
NM_000558.3(HBA1):c.310C>T (p.His104Tyr)	HBA1|LOC106804613	H104Y	HEMOGLOBIN CHAROLLES	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015876	16	227291	16	177292	15876	30915	rs28928884	NC_000016.10:177291:C:T
NM_000558.3(HBA1):c.137A>C (p.His46Pro)	HBA1|LOC106804613	H46P	HEMOGLOBIN OITA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015874	16	226969	16	176970	15874	30913	rs28928883	NC_000016.10:176969:A:C
NM_000558.3(HBA1):c.286C>A (p.Pro96Thr)	HBA1|LOC106804613	P96T	HEMOGLOBIN GODAVARI	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015873	16	227118	16	177119	15873	30912	rs33984621	NC_000016.10:177118:C:A
NM_000558.5(HBA1):c.219C>A (p.His73Gln)	HBA1|HBA2|LOC106804612	H73Q	HEMOGLOBIN GOUDA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015871	16	223247	16	173248	15871	30910		NC_000016.10:173247:C:A
NM_000558.5(HBA1):c.292A>C (p.Asn98His)	HBA1|LOC106804613	N98H	HEMOGLOBIN FUCHU-II	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015870	16	227124	16	177125	15870	30909	rs41322954	NC_000016.10:177124:A:C
NM_000558.3(HBA1):c.217C>T (p.His73Tyr)	HBA1|LOC106804613	H73Y	HEMOGLOBIN FUCHU-I	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015869	16	227049	16	177050	15869	30908	rs36104787	NC_000016.10:177049:C:T
NM_000558.3(HBA1):c.334G>A (p.Ala112Thr)	HBA1|LOC106804613	A112T	HEMOGLOBIN MOSELLA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015868	16	227315	16	177316	15868	30907	rs34863047	NC_000016.10:177315:G:A
NM_000558.3(HBA1):c.197C>T (p.Ala66Val)	HBA1|LOC106804613	A66V	HEMOGLOBIN BOIS GUILLAUME	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015866	16	227029	16	177030	15866	30905	rs34733452	NC_000016.10:177029:C:T
NM_000558.3(HBA1):c.389T>C (p.Leu130Pro)	HBA1|LOC106804613	L130P	not provided	Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000015865	16	227370	16	177371	15865	30904	rs35993655	NC_000016.10:177370:T:C
NM_000558.3(HBA1):c.370G>T (p.Ala124Ser)	HBA1|LOC106804613	A124S	HEMOGLOBIN MALHACEN	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015864	16	227351	16	177352	15864	30903	rs28928881	NC_000016.10:177351:G:T
NM_000558.5(HBA1):c.285C>G (p.Asp95Glu)	HBA1|LOC106804613	D95E	HEMOGLOBIN ROANNE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015863	16	227117	16	177118	15863	30902	rs34814612	NC_000016.10:177117:C:G
NM_000558.3(HBA1):c.72G>T (p.Glu24Asp)	HBA1|LOC106804613	E24D	HEMOGLOBIN LISBON	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015862	16	226787	16	176788	15862	30901	rs281860684	NC_000016.10:176787:G:T
NM_000558.5(HBA1):c.24G>C (p.Lys8Asn)	HBA1|LOC106804613	K8N	not provided	Likely benign(Last reviewed: Jul 27, 2021)	criteria provided, single submitter	VCV000015861	16	226739	16	176740	15861	30900	rs34410516	NC_000016.10:176739:G:C
NM_000558.5(HBA1):c.277C>T (p.Arg93Trp)	HBA1|LOC106804613	R93W	HEMOGLOBIN CEMENELUM	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015859	16	227109	16	177110	15859	30898	rs34868036	NC_000016.10:177109:C:T
NM_000558.5(HBA1):c.343C>T (p.Pro115Ser)	HBA1|LOC106804613	P115S	HEMOGLOBIN MELUSINE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015857	16	227324	16	177325	15857	30896	rs34472107	NC_000016.10:177324:C:T
NM_000558.5(HBA1):c.421T>C (p.Tyr141His)	HBA1|LOC106804613	Y141H	HEMOGLOBIN ROUEN|HEMOGLOBIN ETHIOPIA|Erythrocytosis, familial, 7	Pathogenic; other(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000015856	16	227402	16	177403	15856	30895	rs35723200	NC_000016.10:177402:T:C
NM_000558.5(HBA1):c.379G>T (p.Asp127Tyr)	HBA1|LOC106804613	D127Y	HEMOGLOBIN MONTEFIORE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015855	16	227360	16	177361	15855	30894		NC_000016.10:177360:G:T
NM_000558.5(HBA1):c.284A>G (p.Asp95Gly)	HBA1|LOC106804613	D95G	HEMOGLOBIN CAPA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015854	16	227116	16	177117	15854	30893	rs28928879	NC_000016.10:177116:A:G
NM_000558.5(HBA1):c.392C>A (p.Ala131Asp)	HBA1|LOC106804613	A131D	HEMOGLOBIN YUDA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015853	16	227373	16	177374	15853	30892	rs63750613	NC_000016.10:177373:C:A
NM_000558.5(HBA1):c.398T>G (p.Val133Gly)	HBA1|LOC106804613	V133G	HEMOGLOBIN CAEN	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015852	16	227379	16	177380	15852	30891	rs35166834	NC_000016.10:177379:T:G
NM_000558.5(HBA1):c.136C>G (p.His46Asp)	HBA1|LOC106804613	H46D	HEMOGLOBIN POITIERS	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015851	16	226968	16	176969	15851	30890	rs33931984	NC_000016.10:176968:C:G
NM_000558.5(HBA1):c.56G>A (p.Gly19Asp)	HBA1|LOC106804613	G19D	HEMOGLOBIN AL-AIN ABU DHABI	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015850	16	226771	16	176772	15850	30889	rs35993097	NC_000016.10:176771:G:A
NM_000558.5(HBA1):c.215C>T (p.Ala72Val)	HBA1|LOC106804613	A72V	HEMOGLOBIN OZIERI	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015848	16	227047	16	177048	15848	30887	rs3180281	NC_000016.10:177047:C:T
NM_000558.3(HBA1):c.269A>T (p.His90Leu)	HBA1|LOC106804613	H90L	HEMOGLOBIN LUTON	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015847	16	227101	16	177102	15847	30886	rs33944813	NC_000016.10:177101:A:T
NM_000558.5(HBA1):c.298A>G (p.Lys100Glu)	HBA1|LOC106804613	K100E	HEMOGLOBIN TURRIFF	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015845	16	227130	16	177131	15845	30884	rs34806456	NC_000016.10:177130:A:G
NM_000517.6(HBA2):c.122A>T (p.Lys41Met)	HBA1|HBA2|LOC106804612	K41M	Erythrocytosis, familial, 7|HEMOGLOBIN KANAGAWA	Pathogenic; other(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000015844	16	223150	16	173151	15844	30883	rs281864828	NC_000016.10:173150:A:T
NM_000558.5(HBA1):c.5T>A (p.Val2Glu)	HBA1|LOC106804613	V2E	HEMOGLOBIN THIONVILLE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015843	16	226720	16	176721	15843	30882	rs281864802	NC_000016.10:176720:T:A
NM_000558.5(HBA1):c.394T>C (p.Ser132Pro)	HBA1|LOC106804613	S132P	HEMOGLOBIN QUESTEMBERT	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015842	16	227375	16	177376	15842	30881	rs35974739	NC_000016.10:177375:T:C
NM_000558.5(HBA1):c.407T>A (p.Val136Glu)	HBA1|LOC106804613	V136E	HEMOGLOBIN PAVIE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015841	16	227388	16	177389	15841	30880	rs35994191	NC_000016.10:177388:T:A
NM_000558.3(HBA1):c.170A>G (p.Lys57Arg)	HBA1|LOC106804613	K57R	HEMOGLOBIN PORT HURON	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015840	16	227002	16	177003	15840	30879	rs33949106	NC_000016.10:177002:A:G
NM_000558.5(HBA1):c.380A>T (p.Asp127Val)	HBA1|LOC106804613	D127V	HEMOGLOBIN FUKUTOMI	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015839	16	227361	16	177362	15839	30878	rs63750467	NC_000016.10:177361:A:T
NM_000558.3(HBA1):c.171G>C (p.Lys57Asn)	HBA1|LOC106804613	K57N	HEMOGLOBIN BELLIARD	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015837	16	227003	16	177004	15837	30876	rs281860657	NC_000016.10:177003:G:C
NM_000558.3(HBA1):c.19G>T (p.Asp7Tyr)	HBA1|LOC106804613	D7Y	HEMOGLOBIN WOODVILLE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015835	16	226734	16	176735	15835	30874	rs33961916	NC_000016.10:176734:G:T
NM_000558.3(HBA1):c.226G>T (p.Asp76Tyr)	HBA1|LOC106804613	D76Y	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 17, 2021)	criteria provided, conflicting interpretations	VCV000015834	16	227058	16	177059	15834	30873	rs33977363	NC_000016.10:177058:G:T
NM_000558.5(HBA1):c.350A>C (p.Glu117Ala)	HBA1|LOC106804613	E117A	not provided	Likely benign(Last reviewed: Sep 8, 2021)	criteria provided, single submitter	VCV000015832	16	227331	16	177332	15832	30871	rs35932809	NC_000016.10:177331:A:C
NM_000558.5(HBA1):c.205A>G (p.Asn69Asp)	HBA1|LOC106804613	N69D	not provided	Uncertain significance(Last reviewed: Jun 3, 2021)	criteria provided, single submitter	VCV000015831	16	227037	16	177038	15831	30870	rs34823698	NC_000016.10:177037:A:G
NM_000558.3(HBA1):c.34A>C (p.Lys12Gln)	HBA1|LOC106804613	K12Q	HEMOGLOBIN WUMING|HEMOGLOBIN J (WENCHANG-WUMING)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015830	16	226749	16	176750	15830	30869	rs33938574	NC_000016.10:176749:A:C
NM_000558.3(HBA1):c.341T>A (p.Leu114His)	HBA1|LOC106804613	L114H	not provided	Likely benign(Last reviewed: Apr 1, 2022)	criteria provided, single submitter	VCV000015829	16	227322	16	177323	15829	30868	rs35654345	NC_000016.10:177322:T:A
NM_000558.5(HBA1):c.410T>G (p.Leu137Arg)	HBA1|LOC106804613	L137R	Heinz body anemia|HEMOGLOBIN TOYAMA	Pathogenic; other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015828	16	227391	16	177392	15828	30867	rs34635364	NC_000016.10:177391:T:G
NM_000558.3(HBA1):c.179G>T (p.Gly60Val)	HBA1|LOC106804613	G60V	HEMOGLOBIN TOTTORI	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015827	16	227011	16	177012	15827	30866	rs28928878	NC_000016.10:177011:G:T
NM_000558.5(HBA1):c.130T>G (p.Phe44Val)	HBA1|LOC106804613	F44V	HEMOGLOBIN TORINO	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015826	16	226962	16	176963	15826	30865	rs35511459	NC_000016.10:176962:T:G
NM_000558.5(HBA1):c.419A>C (p.Lys140Thr)	HBA1|LOC106804613	K140T	HEMOGLOBIN TOKONAME	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015825	16	227400	16	177401	15825	30864	rs34849179	NC_000016.10:177400:A:C
NM_000558.3(HBA1):c.283G>A (p.Asp95Asn)	HBA1|LOC106804613	D95N	HEMOGLOBIN TITUSVILLE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015824	16	227115	16	177116	15824	30863	rs34102339	NC_000016.10:177115:G:A
NM_000558.3(HBA1):c.170A>C (p.Lys57Thr)	HBA1|LOC106804613	K57T	HEMOGLOBIN THAILAND	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015823	16	227002	16	177003	15823	30862	rs33949106	NC_000016.10:177002:A:C
NM_000558.3(HBA1):c.20A>G (p.Asp7Gly)	HBA1|LOC106804613	D7G	not provided	Uncertain significance(Last reviewed: Apr 6, 2020)	criteria provided, single submitter	VCV000015822	16	226735	16	176736	15822	30861	rs33986902	NC_000016.10:176735:A:G
NM_000558.3(HBA1):c.425G>A (p.Arg142His)	HBA1|LOC106804613	R142H	HEMOGLOBIN SURESNES|Erythrocytosis, familial, 7	Pathogenic; other(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000015821	16	227406	16	177407	15821	30860	rs33935328	NC_000016.10:177406:G:A
NM_000558.3(HBA1):c.283G>C (p.Asp95His)	HBA1|LOC106804613	D95H	not provided	Uncertain significance(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000015820	16	227115	16	177116	15820	30859	rs34102339	NC_000016.10:177115:G:C
NM_000558.5(HBA1):c.338A>G (p.His113Arg)	HBA1|LOC106804613	H113R	HEMOGLOBIN STRUMICA|HEMOGLOBIN SERBIA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015819	16	227319	16	177320	15819	30858	rs34713708	NC_000016.10:177319:A:G
NM_000558.5(HBA1):c.237C>G (p.Asn79Lys)	HBA1|LOC106804613	N79K	HEMOGLOBIN STANLEYVILLE-II	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015818	16	227069	16	177070	15818	30857	rs34440919	NC_000016.10:177069:C:G
NM_000558.3(HBA1):c.287C>G (p.Pro96Arg)	HBA1|LOC106804613	P96R	not provided	Uncertain significance(Last reviewed: Mar 5, 2021)	criteria provided, single submitter	VCV000015817	16	227119	16	177120	15817	30856	rs33931314	NC_000016.10:177119:C:G
NM_000558.5(HBA1):c.383A>C (p.Lys128Thr)	HBA1|LOC106804613	K128T	HEMOGLOBIN ST. CLAUDE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015816	16	227364	16	177365	15816	30855	rs63751308	NC_000016.10:177364:A:C
NM_000558.3(HBA1):c.425G>C (p.Arg142Pro)	HBA1|LOC106804613	R142P	HEMOGLOBIN SINGAPORE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015815	16	227406	16	177407	15815	30854	rs33935328	NC_000016.10:177406:G:C
NM_000558.5(HBA1):c.82G>A (p.Glu28Lys)	HBA1|LOC106804613	E28K	HEMOGLOBIN SHUANGFENG	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015814	16	226797	16	176798	15814	30853	rs34776279	NC_000016.10:176797:G:A
NM_000558.5(HBA1):c.164A>G (p.Gln55Arg)	HBA1|LOC106804613	Q55R	HEMOGLOBIN HIKOSHIMA|HEMOGLOBIN SHIMONOSEKI	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015813	16	226996	16	176997	15813	30852	rs36024711	NC_000016.10:176996:A:G
NM_000558.3(HBA1):c.80C>A (p.Ala27Glu)	HBA1|LOC106804613	A27E	HEMOGLOBIN SHENYANG	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015812	16	226795	16	176796	15812	30851	rs35477770	NC_000016.10:176795:C:A
NM_000558.5(HBA1):c.169A>G (p.Lys57Glu)	HBA1|LOC106804613	K57E	HEMOGLOBIN SHAARE ZEDEK	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015811	16	227001	16	177002	15811	30850	rs34182019	NC_000016.10:177001:A:G
NM_000558.3(HBA1):c.283G>T (p.Asp95Tyr)	HBA1|LOC106804613	D95Y	HEMOGLOBIN SETIF	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015810	16	227115	16	177116	15810	30849	rs34102339	NC_000016.10:177115:G:T
NM_000558.3(HBA1):c.20A>C (p.Asp7Ala)	HBA1|LOC106804613	D7A	HEMOGLOBIN SAWARA	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015809	16	226735	16	176736	15809	30848	rs33986902	NC_000016.10:176735:A:C
NM_000517.6(HBA2):c.150C>A (p.Ser50Arg)	HBA1|HBA2|LOC106804612	S50R	not provided	Uncertain significance(Last reviewed: May 19, 2022)	criteria provided, single submitter	VCV000015808	16	223178	16	173179	15808	30847	rs41518249	NC_000016.10:173178:C:A
NM_000558.5(HBA1):c.379G>C (p.Asp127His)	HBA1|LOC106804613	D127H	HEMOGLOBIN SASSARI|Erythrocytosis, familial, 7	Pathogenic; other(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000015807	16	227360	16	177361	15807	30846	rs63750950	NC_000016.10:177360:G:C
NM_000558.3(HBA1):c.154G>C (p.Gly52Arg)	HBA1|LOC106804613	G52R	not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 2, 2022)	criteria provided, conflicting interpretations	VCV000015806	16	226986	16	176987	15806	30845	rs33960522	NC_000016.10:176986:G:C
NM_000558.3(HBA1):c.71A>G (p.Glu24Gly)	HBA1|LOC106804613	E24G	HEMOGLOBIN REIMS	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015805	16	226786	16	176787	15805	30844	rs33939421	NC_000016.10:176786:A:G
NM_000558.3(HBA1):c.226G>C (p.Asp76His)	HBA1|LOC106804613	D76H	HEMOGLOBIN Q (IRAN)	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015804	16	227058	16	177059	15804	30843	rs33977363	NC_000016.10:177058:G:C
NM_000558.3(HBA1):c.193G>C (p.Asp65His)	HBA1|LOC106804613	D65H	not provided	Uncertain significance(Last reviewed: Sep 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015803	16	227025	16	177026	15803	30842	rs33984024	NC_000016.10:177025:G:C
NM_000558.5(HBA1):c.275T>C (p.Leu92Pro)	HBA1|LOC106804613	L92P	HEMOGLOBIN PORT PHILLIP	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015802	16	227107	16	177108	15802	30841	rs34684963	NC_000016.10:177107:T:C
NM_000558.5(HBA1):c.191C>A (p.Ala64Asp)	HBA1|LOC106804613	A64D	HEMOGLOBIN PONTOISE|HEMOGLOBIN J (PONTOISE)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015801	16	227023	16	177024	15801	30840	rs34502246	NC_000016.10:177023:C:A
NM_000558.5(HBA1):c.332C>A (p.Ala111Asp)	HBA1|LOC106804613	A111D	Heinz body anemia|alpha Thalassemia|Hemoglobin H disease|Methemoglobinemia, alpha type|Erythrocytosis, familial, 7|not provided	Likely pathogenic(Last reviewed: Apr 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015800	16	227313	16	177314	15800	30839	rs63749948	NC_000016.10:177313:C:A
NM_000558.3(HBA1):c.193G>T (p.Asp65Tyr)	HBA1|LOC106804613	D65Y	HEMOGLOBIN PERSPOLIS	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015799	16	227025	16	177026	15799	30838	rs33984024	NC_000016.10:177025:G:T
NM_000558.5(HBA1):c.364G>A (p.Val122Met)	HBA1|LOC106804613	V122M	not specified|not provided	Uncertain significance(Last reviewed: Aug 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015798	16	227345	16	177346	15798	30837	rs63751008	NC_000016.10:177345:G:A
NM_000558.5(HBA1):c.46G>C (p.Gly16Arg)	HBA1|LOC106804613	G16R	HEMOGLOBIN SIAM|HEMOGLOBIN OTTAWA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015797	16	226761	16	176762	15797	30836	rs35816645	NC_000016.10:176761:G:C
NM_000558.3(HBA1):c.349G>C (p.Glu117Gln)	HBA1|LOC106804613	E117Q	HEMOGLOBIN OLEANDER	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015796	16	227330	16	177331	15796	30835	rs63749882	NC_000016.10:177330:G:C
NM_000558.5(HBA1):c.91G>A (p.Glu31Lys)	HBA1|LOC106804613	E31K	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 7, 2020)	criteria provided, conflicting interpretations	VCV000015794	16	226806	16	176807	15794	30833	rs33993166	NC_000016.10:176806:G:A
NM_000558.3(HBA1):c.349G>A (p.Glu117Lys)	HBA1|LOC106804613	E117K	not provided	Likely benign(Last reviewed: Oct 24, 2022)	criteria provided, single submitter	VCV000015793	16	227330	16	177331	15793	30832	rs63749882	NC_000016.10:177330:G:A
NM_000558.3(HBA1):c.424C>T (p.Arg142Cys)	HBA1|LOC106804613	R142C	HEMOGLOBIN NUNOBIKI|Erythrocytosis, familial, 7	Pathogenic; other(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000015792	16	227405	16	177406	15792	30831	rs33991910	NC_000016.10:177405:C:T
NM_000558.3(HBA1):c.344C>T (p.Pro115Leu)	HBA1|LOC106804613	P115L	HEMOGLOBIN NOUAKCHOTT	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015791	16	227325	16	177326	15791	30830	rs33910377	NC_000016.10:177325:C:T
NM_000558.5(HBA1):c.173G>A (p.Gly58Asp)	HBA1|LOC106804613	G58D	HEMOGLOBIN NORFOLK|HEMOGLOBIN J (NORFOLK)|HEMOGLOBIN KAGOSHIMA|HEMOGLOBIN NISHIK	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015790	16	227005	16	177006	15790	30829	rs36062788	NC_000016.10:177005:G:A
NM_000558.3(HBA1):c.230T>A (p.Met77Lys)	HBA1|LOC106804613	M77K	HEMOGLOBIN NOKO	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015789	16	227062	16	177063	15789	30828	rs33969953	NC_000016.10:177062:T:A
NM_000558.5(HBA1):c.245C>G (p.Ser82Cys)	HBA1|LOC106804613	S82C	HEMOGLOBIN NIGERIA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015788	16	227077	16	177078	15788	30827	rs34936612	NC_000016.10:177077:C:G
NM_000558.3(HBA1):c.61C>T (p.His21Tyr)	HBA1|LOC106804613	H21Y	HEMOGLOBIN NECKER ENFANTS-MALADES	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015787	16	226776	16	176777	15787	30826	rs34708054	NC_000016.10:176776:C:T
NM_000558.5(HBA1):c.260T>G (p.Leu87Arg)	HBA1|LOC106804613	L87R	HEMOGLOBIN MOABIT	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015786	16	227092	16	177093	15786	30825	rs35548338	NC_000016.10:177092:T:G
NM_000558.3(HBA1):c.227A>G (p.Asp76Gly)	HBA1|LOC106804613	D76G	HEMOGLOBIN MIZUSHI	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015785	16	227059	16	177060	15785	30824	rs33991223	NC_000016.10:177059:A:G
NM_000558.5(HBA1):c.124A>T (p.Thr42Ser)	HBA1|LOC106804613	T42S	HEMOGLOBIN MIYANO	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015784	16	226956	16	176957	15784	30823	rs34890875	NC_000016.10:176956:A:T
NM_000558.3(HBA1):c.134C>T (p.Pro45Leu)	HBA1|LOC106804613	P45L	not provided	Likely pathogenic(Last reviewed: Dec 16, 2021)	criteria provided, single submitter	VCV000015783	16	226966	16	176967	15783	30822	rs33978134	NC_000016.10:176966:C:T
NM_000558.5(HBA1):c.163C>G (p.Gln55Glu)	HBA1|LOC106804613	Q55E	not provided	Benign/Likely benign(Last reviewed: Dec 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000015782	16	226995	16	176996	15782	30821	rs35317336	NC_000016.10:176995:C:G
NM_000558.3(HBA1):c.70G>C (p.Glu24Gln)	HBA1|LOC106804613	E24Q	HEMOGLOBIN MEMPHIS	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015781	16	226785	16	176786	15781	30820	rs33939620	NC_000016.10:176785:G:C
NM_000558.3(HBA1):c.226G>A (p.Asp76Asn)	HBA1|LOC106804613	D76N	HEMOGLOBIN MATSUE-OKI	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015780	16	227058	16	177059	15780	30819	rs33977363	NC_000016.10:177058:G:A
NM_000558.5(HBA1):c.175C>T (p.His59Tyr)	HBA1|LOC106804613	H59Y	HEMOGLOBIN M (OSAKA)|HEMOGLOBIN M (KISKUNHALAS)|HEMOGLOBIN M (BOSTON)|HEMOGLOBIN GOTHENBURG|HEMOGLOBIN M (GOTHENBURG)	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015778	16	227007	16	177008	15778	30817	rs35213748	NC_000016.10:177007:C:T
NM_000558.5(HBA1):c.73T>C (p.Tyr25His)	HBA1|LOC106804613	Y25H	HEMOGLOBIN LUXEMBOURG	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015777	16	226788	16	176789	15777	30816	rs34743106	NC_000016.10:176788:T:C
NM_000558.5(HBA1):c.265G>T (p.Ala89Ser)	HBA1|LOC106804613	A89S	HEMOGLOBIN LOIRE|Erythrocytosis, familial, 7	Pathogenic; other(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000015776	16	227097	16	177098	15776	30815	rs35239527	NC_000016.10:177097:G:T
NM_000558.3(HBA1):c.224A>C (p.Asp75Ala)	HBA1|LOC106804613	D75A	HEMOGLOBIN LILLE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015775	16	227056	16	177057	15775	30814	rs33921047	NC_000016.10:177056:A:C
NM_000517.6:c.63C>A	HBA1|HBA2|LOC106804612	H21Q	HEMOGLOBIN LE LAMENTIN	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015774	16	222974	16	172975	15774	30813		NC_000016.10:172974:C:A
NM_000558.3(HBA1):c.425G>T (p.Arg142Leu)	HBA1|LOC106804613	R142L	HEMOGLOBIN LEGNANO|Erythrocytosis, familial, 7	Pathogenic; other(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000015773	16	227406	16	177407	15773	30812	rs33935328	NC_000016.10:177406:G:T
NM_000558.5(HBA1):c.172G>C (p.Gly58Arg)	HBA1|LOC106804613	G58R	HEMOGLOBIN L (PERSIAN GULF)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015772	16	227004	16	177005	15772	30811	rs35252931	NC_000016.10:177004:G:C
NM_000558.3(HBA1):c.143A>G (p.Asp48Gly)	HBA1|LOC106804613	D48G	HEMOGLOBIN UMI|HEMOGLOBIN MUGINO|HEMOGLOBIN YUKUHASHI-2|HEMOGLOBIN KOKURA|HEMOGLOBIN BEILINSON|HEMOGLOBIN MICHIGAN-I|HEMOGLOBIN MICHIGAN-II|HEMOGLOBIN L (GASLINI)|HEMOGLOBIN TAGAWA II	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015771	16	226975	16	176976	15771	30810	rs33944368	NC_000016.10:176975:A:G
NM_000558.3(HBA1):c.134C>G (p.Pro45Arg)	HBA1|LOC106804613	P45R	HEMOGLOBIN KAWACHI	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015769	16	226966	16	176967	15769	30808	rs33978134	NC_000016.10:176966:C:G
NM_000558.5(HBA1):c.121A>G (p.Lys41Glu)	HBA1|LOC106804613	K41E	HEMOGLOBIN KARIYA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015768	16	226953	16	176954	15768	30807	rs34492931	NC_000016.10:176953:A:G
NM_000558.5(HBA1):c.16G>C (p.Ala6Pro)	HBA1|LOC106804613	A6P	HEMOGLOBIN KARACHI	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015767	16	226731	16	176732	15767	30806	rs34751764	NC_000016.10:176731:G:C
NM_000558.5(HBA1):c.384G>C (p.Lys128Asn)	HBA1|LOC106804613	K128N	HEMOGLOBIN JACKSON	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015766	16	227365	16	177366	15766	30805	rs63749865	NC_000016.10:177365:G:C
NM_000558.5(HBA1):c.17C>A (p.Ala6Asp)	HBA1|LOC106804613	A6D	not provided	Uncertain significance(Last reviewed: Aug 16, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015765	16	226732	16	176733	15765	30804	rs34090856	NC_000016.10:176732:C:A
NM_000558.5(HBA1):c.347C>A (p.Ala116Asp)	HBA1|LOC106804613	A116D	HEMOGLOBIN J (TONGARIKI)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015764	16	227328	16	177329	15764	30803	rs34204059	NC_000016.10:177328:C:A
NM_000558.5(HBA1):c.59C>A (p.Ala20Glu)	HBA1|LOC106804613	A20E	HEMOGLOBIN J (TASHIKUERGAN)	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015763	16	226774	16	176775	15763	30802	rs35628685	NC_000016.10:176774:C:A
NM_000558.5(HBA1):c.161C>A (p.Ala54Asp)	HBA1|LOC106804613	A54D	HEMOGLOBIN J (ROVIGO)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015760	16	226993	16	176994	15760	30799	rs34574239	NC_000016.10:176993:C:A
NM_000558.3(HBA1):c.272A>C (p.Lys91Thr)	HBA1|LOC106804613	K91T	not provided	Likely benign(Last reviewed: Jun 11, 2021)	criteria provided, single submitter	VCV000015759	16	227104	16	177105	15759	30798	rs33911106	NC_000016.10:177104:A:C
NM_000558.5(HBA1):c.38C>A (p.Ala13Asp)	HBA1|LOC106804613	A13D	HEMOGLOBIN J (PARIS 1)|HEMOGLOBIN J (ALJEZUR)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015758	16	226753	16	176754	15758	30797	rs35615982	NC_000016.10:176753:C:A
NM_000558.5(HBA1):c.65C>A (p.Ala22Asp)	HBA1|LOC106804613	A22D	HEMOGLOBIN J (NYANZA)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015757	16	226780	16	176781	15757	30796	rs11548605	NC_000016.10:176780:C:A
NM_000558.5(HBA1):c.68G>A (p.Gly23Asp)	HBA1|LOC106804613	G23D	HEMOGLOBIN J (MEDELLIN)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015756	16	226783	16	176784	15756	30795	rs34608326	NC_000016.10:176783:G:A
NM_000558.5(HBA1):c.215C>A (p.Ala72Glu)	HBA1|LOC106804613	A72E	HEMOGLOBIN J (HABANA)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015754	16	227047	16	177048	15754	30793	rs3180281	NC_000016.10:177047:C:A
NM_000558.3(HBA1):c.424C>A (p.Arg142Ser)	HBA1|LOC106804613	R142S	HEMOGLOBIN J (CUBUJUQUI)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015753	16	227405	16	177406	15753	30792	rs33991910	NC_000016.10:177405:C:A
NM_000558.3(HBA1):c.278G>A (p.Arg93Gln)	HBA1|LOC106804613	R93Q	HEMOGLOBIN J (CAPE TOWN)|Erythrocytosis, familial, 7	Pathogenic; other(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000015752	16	227110	16	177111	15752	30791	rs33991779	NC_000016.10:177110:G:A
NM_000558.3(HBA1):c.424C>G (p.Arg142Gly)	HBA1|LOC106804613	R142G	HEMOGLOBIN J (CAMAGUEY)	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015751	16	227405	16	177406	15751	30790	rs33991910	NC_000016.10:177405:C:G
NM_000558.5(HBA1):c.362C>A (p.Ala121Glu)	HBA1|LOC106804613	A121E	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 11, 2022)	criteria provided, conflicting interpretations	VCV000015750	16	227343	16	177344	15750	30789	rs63749927	NC_000016.10:177343:C:A
NM_000558.5(HBA1):c.185A>C (p.Lys62Thr)	HBA1|LOC106804613	K62T	HEMOGLOBIN J (ANATOLIA)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015749	16	227017	16	177018	15749	30788	rs41381645	NC_000016.10:177017:A:C
NM_000558.5(HBA1):c.155G>A (p.Gly52Asp)	HBA1|LOC106804613	G52D	HEMOGLOBIN J (ABIDJAN)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015748	16	226987	16	176988	15748	30787	rs35934411	NC_000016.10:176987:G:A
NM_000558.5(HBA1):c.263A>G (p.His88Arg)	HBA1|LOC106804613	H88R	HEMOGLOBIN IWATA	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015747	16	227095	16	177096	15747	30786	rs33976776	NC_000016.10:177095:A:G
NM_000558.3(HBA1):c.49A>G (p.Lys17Glu)	HBA1|LOC106804613	K17E	not specified|not provided	Likely benign(Last reviewed: Jun 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015746	16	226764	16	176765	15746	30785	rs41407250	NC_000016.10:176764:A:G
NM_000558.5(HBA1):c.337C>G (p.His113Asp)	HBA1|LOC106804613	H113D	not provided	Uncertain significance(Last reviewed: Nov 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015745	16	227318	16	177319	15745	30784	rs34830032	NC_000016.10:177318:C:G
NM_000558.5(HBA1):c.62A>G (p.His21Arg)	HBA1|LOC106804613	H21R	HEMOGLOBIN HOBART	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015744	16	226777	16	176778	15744	30783	rs33943087	NC_000016.10:176777:A:G
NM_000558.5(HBA1):c.132C>G (p.Phe44Leu)	HBA1|HBA2|LOC106804612	F44L	HEMOGLOBIN HIROSAKI	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015743	16	223160	16	173161	15743	30782		NC_000016.10:173160:C:G
NM_000558.5(HBA1):c.84G>T (p.Glu28Asp)	HBA1|LOC106804613	E28D	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 7, 2022)	criteria provided, conflicting interpretations	VCV000015742	16	226799	16	176800	15742	30781	rs41530750	NC_000016.10:176799:G:T
NM_000558.5(HBA1):c.50A>T (p.Lys17Met)	HBA1|LOC106804613	K17M	HEMOGLOBIN HARBIN	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015741	16	226765	16	176766	15741	30780	rs35210126	NC_000016.10:176765:A:T
NM_000558.3(HBA1):c.272A>T (p.Lys91Met)	HBA1|LOC106804613	K91M	HEMOGLOBIN HANDA|HEMOGLOBIN MUNAKATA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015740	16	227104	16	177105	15740	30779	rs33911106	NC_000016.10:177104:A:T
NM_000558.3(HBA1):c.233C>G (p.Pro78Arg)	HBA1|LOC106804613	P78R	HEMOGLOBIN GUIZHOU|HEMOGLOBIN UTSUNOMIYA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015739	16	227065	16	177066	15739	30778	rs34019158	NC_000016.10:177065:C:G
NM_000558.5(HBA1):c.194A>G (p.Asp65Gly)	HBA1|LOC106804613	D65G	HEMOGLOBIN HANGZHOU|HEMOGLOBIN GUANGZHOU	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015738	16	227026	16	177027	15738	30777	rs35873730	NC_000016.10:177026:A:G
NM_000558.5(HBA1):c.55G>C (p.Gly19Arg)	HBA1|LOC106804613	G19R	HEMOGLOBIN HANDSWORTH	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015736	16	226770	16	176771	15736	30775	rs34504387	NC_000016.10:176770:G:C
NM_000558.3(HBA1):c.248C>A (p.Ala83Asp)	HBA1|LOC106804613	A83D	HEMOGLOBIN GARDEN STATE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015735	16	227080	16	177081	15735	30774	rs34879587	NC_000016.10:177080:C:A
NM_000558.5(HBA1):c.193G>A (p.Asp65Asn)	HBA1|LOC106804613	D65N	HEMOGLOBIN AIDA|HEMOGLOBIN G (WAIMANALO)	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015734	16	227025	16	177026	15734	30773	rs33984024	NC_000016.10:177025:G:A
NM_000558.5(HBA1):c.223G>C (p.Asp75His)	HBA1|LOC106804613	D75H	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2019)	criteria provided, conflicting interpretations	VCV000015733	16	227055	16	177056	15733	30772	rs28928875	NC_000016.10:177055:G:C
NM_000558.5(HBA1):c.223G>A (p.Asp75Asn)	HBA1|LOC106804613	D75N	not provided	Uncertain significance(Last reviewed: Jan 15, 2021)	criteria provided, single submitter	VCV000015732	16	227055	16	177056	15732	30771	rs28928875	NC_000016.10:177055:G:A
NM_000558.3(HBA1):c.256G>A (p.Asp86Asn)	HBA1|LOC106804613	D86N	not provided	Uncertain significance(Last reviewed: Mar 31, 2021)	criteria provided, single submitter	VCV000015731	16	227088	16	177089	15731	30770	rs33915947	NC_000016.10:177088:G:A
NM_000558.3(HBA1):c.83A>G (p.Glu28Gly)	HBA1|LOC106804613	E28G	HEMOGLOBIN G (FORT WORTH)|HEMOGLOBIN FORT WORTH	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015729	16	226798	16	176799	15729	30768	rs33964507	NC_000016.10:176798:A:G
NM_000558.3(HBA1):c.71A>T (p.Glu24Val)	HBA1|LOC106804613	E24V	HEMOGLOBIN G (AUDHALI)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015728	16	226786	16	176787	15728	30767	rs33939421	NC_000016.10:176786:A:T
NM_000558.3(HBA1):c.137A>G (p.His46Arg)	HBA1|LOC106804613	H46R	HEMOGLOBIN FORT DE FRANCE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015727	16	226969	16	176970	15727	30766	rs28928883	NC_000016.10:176969:A:G
NM_000558.5(HBA1):c.64G>C (p.Ala22Pro)	HBA1|LOC106804613	A22P	HEMOGLOBIN FONTAINEBLEAU	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015726	16	226779	16	176780	15726	30765	rs34324664	NC_000016.10:176779:G:C
NM_000558.3(HBA1):c.20A>T (p.Asp7Val)	HBA1|LOC106804613	D7V	HEMOGLOBIN FERNDOWN	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015725	16	226735	16	176736	15725	30764	rs33986902	NC_000016.10:176735:A:T
NM_000558.5(HBA1):c.43T>Y (p.Trp15Xaa)	HBA1|LOC106804613	W15*	HEMOGLOBIN EVANSTON	other(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000015724	16	226758	16	176759	15724	30763	rs33964317	NC_000016.10:176758:T:Y
NM_000558.5(HBA1):c.253A>C (p.Ser85Arg)	HBA1|LOC106804613	S85R	HEMOGLOBIN ETOBICOKE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015723	16	227085	16	177086	15723	30762	rs33926206	NC_000016.10:177085:A:C
NM_000558.3(HBA1):c.19G>A (p.Asp7Asn)	HBA1|LOC106804613	D7N	HEMOGLOBIN DUNN	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015722	16	226734	16	176735	15722	30761	rs33961916	NC_000016.10:176734:G:A
NM_000558.3(HBA1):c.227A>C (p.Asp76Ala)	HBA1|LOC106804613	D76A	HEMOGLOBIN DUAN	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015721	16	227059	16	177060	15721	30760	rs33991223	NC_000016.10:177059:A:C
NM_000558.3(HBA1):c.286C>G (p.Pro96Ala)	HBA1|LOC106804613	P96A	HEMOGLOBIN DENMARK HILL	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015720	16	227118	16	177119	15720	30759	rs33984621	NC_000016.10:177118:C:G
NM_000558.5(HBA1):c.218A>G (p.His73Arg)	HBA1|LOC106804613	H73R	HEMOGLOBIN DANESHGAH-TEHRAN	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015719	16	227050	16	177051	15719	30758	rs35859529	NC_000016.10:177050:A:G
NM_000558.5(HBA1):c.181A>G (p.Lys61Glu)	HBA1|LOC106804613	K61E	HEMOGLOBIN DAGESTAN	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015717	16	227013	16	177014	15717	30756	rs34259907	NC_000016.10:177013:A:G
NM_000558.3(HBA1):c.143A>C (p.Asp48Ala)	HBA1|LOC106804613	D48A	HEMOGLOBIN CORDELE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015716	16	226975	16	176976	15716	30755	rs33944368	NC_000016.10:176975:A:C
NM_000558.5(HBA1):c.311A>G (p.His104Arg)	HBA1|LOC106804613	H104R	HEMOGLOBIN CONTALDO	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015715	16	227292	16	177293	15715	30754	rs35329201	NC_000016.10:177292:A:G
NM_000558.5(HBA1):c.8T>G (p.Leu3Arg)	HBA1|LOC106804613	L3R	HEMOGLOBIN CHONGQING	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015714	16	226723	16	176724	15714	30753	rs36030576	NC_000016.10:176723:T:G
NM_000558.5(HBA1):c.409C>A (p.Leu137Met)	HBA1|LOC106804613	L137M	HEMOGLOBIN CHICAGO	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015713	16	227390	16	177391	15713	30752	rs121913127	NC_000016.10:177390:C:A
NM_000558.3(HBA1):c.344C>G (p.Pro115Arg)	HBA1|LOC106804613	P115R	not provided	Uncertain significance(Last reviewed: Apr 23, 2020)	criteria provided, single submitter	VCV000015712	16	227325	16	177326	15712	30751	rs33910377	NC_000016.10:177325:C:G
NM_000558.3(HBA1):c.278G>T (p.Arg93Leu)	HBA1|LOC106804613	R93L	HEMOGLOBIN CHESAPEAKE|Erythrocytosis, familial, 7	Pathogenic; other(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000015711	16	227110	16	177111	15711	30750	rs33991779	NC_000016.10:177110:G:T
NM_000558.3(HBA1):c.224A>G (p.Asp75Gly)	HBA1|LOC106804613	D75G	HEMOGLOBIN CHAPEL HILL	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015710	16	227056	16	177057	15710	30749	rs33921047	NC_000016.10:177056:A:G
NM_000558.3(HBA1):c.70G>A (p.Glu24Lys)	HBA1|LOC106804613	E24K	HEMOGLOBIN CHAD	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015709	16	226785	16	176786	15709	30748	rs33939620	NC_000016.10:176785:G:A
NM_000558.5(HBA1):c.273G>C (p.Lys91Asn)	HBA1|LOC106804613	K91N	not provided	Likely benign(Last reviewed: Sep 20, 2022)	criteria provided, single submitter	VCV000015707	16	227105	16	177106	15707	30746	rs33914470	NC_000016.10:177105:G:C
NM_000558.3(HBA1):c.113C>G (p.Pro38Arg)	HBA1|LOC106804613	P38R	HEMOGLOBIN BOURMEDES	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015706	16	226945	16	176946	15706	30745	rs35776155	NC_000016.10:176945:C:G
NM_000558.3(HBA1):c.51G>C (p.Lys17Asn)	HBA1|LOC106804613	K17N	HEMOGLOBIN BEIJING	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015704	16	226766	16	176767	15704	30743	rs281860648	NC_000016.10:176766:G:C
NM_000558.5(HBA1):c.138C>G (p.His46Gln)	HBA1|LOC106804613	H46Q	HEMOGLOBIN BARI	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015703	16	226970	16	176971	15703	30742	rs281860685	NC_000016.10:176970:C:G
NM_000558.3(HBA1):c.230T>C (p.Met77Thr)	HBA1|LOC106804613	M77T	HEMOGLOBIN AZTEC	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015702	16	227062	16	177063	15702	30741	rs33969953	NC_000016.10:177062:T:C
NM_000558.5(HBA1):c.415T>C (p.Ser139Pro)	HBA1|LOC106804613	S139P	HEMOGLOBIN ATTLEBORO	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015701	16	227396	16	177397	15701	30740	rs34011123	NC_000016.10:177396:T:C
NM_000558.3(HBA1):c.256G>T (p.Asp86Tyr)	HBA1|LOC106804613	D86Y	HEMOGLOBIN ATAGO	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015700	16	227088	16	177089	15700	30739	rs33915947	NC_000016.10:177088:G:T
NM_000558.3(HBA1):c.142G>A (p.Asp48Asn)	HBA1|LOC106804613	D48N	not provided	Uncertain significance(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000015699	16	226974	16	176975	15699	30738	rs34269448	NC_000016.10:176974:G:A
NM_000558.5(HBA1):c.242T>G (p.Leu81Arg)	HBA1|LOC106804613	L81R	HEMOGLOBIN ANN ARBOR	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015698	16	227074	16	177075	15698	30737	rs34071856	NC_000016.10:177074:T:G
NM_000558.5(HBA1):c.34A>G (p.Lys12Glu)	HBA1|LOC106804613	K12E	HEMOGLOBIN ANANTHARAJ	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015697	16	226749	16	176750	15697	30736	rs33938574	NC_000016.10:176749:A:G
NM_000558.5(HBA1):c.36G>C (p.Lys12Asn)	HBA1|LOC106804613	K12N	HEMOGLOBIN ALBANY-GEORGIA|HEMOGLOBIN ALBANY-SUMA	other(Last reviewed: May 10, 2018)	no assertion criteria provided	VCV000015696	16	226751	16	176752	15696	30735	rs281860646	NC_000016.10:176751:G:C
NM_000558.5(HBA1):c.152A>G (p.His51Arg)	HBA1|LOC106804613	H51R	HEMOGLOBIN AICHI	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015695	16	226984	16	176985	15695	30734	rs33967561	NC_000016.10:176984:A:G
NM_000517.6(HBA2):c.410T>C (p.Leu137Pro)	HBA2|HBA1|LOC106804612	L137P	Splenomegaly|Anemia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000015655	16	223580	16	173581	15655	30694	rs41469945	NC_000016.10:173580:T:C
NM_000517.6(HBA2):c.294C>A (p.Asn98Lys)	LOC106804612|HBA1|HBA2	N98K	not provided	Uncertain significance(Last reviewed: Apr 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV001330062	16	223322	16	173323	1330062	1320745		NC_000016.10:173322:C:A
NM_000558.5(HBA1):c.1A>G (p.Met1Val)	LOC106804613|HBA1	M1V	not provided	Pathogenic(Last reviewed: Apr 21, 2022)	criteria provided, single submitter	VCV002428673	16	226716	16	176717	2428673	2402115		NC_000016.10:176716:A:G
NM_000558.5(HBA1):c.237C>A (p.Asn79Lys)	LOC106804613|HBA1	N79K	not provided	Benign(Last reviewed: Apr 28, 2022)	criteria provided, single submitter	VCV002428547	16	227069	16	177070	2428547	2401989		NC_000016.10:177069:C:A
NM_000558.5(HBA1):c.255C>A (p.Ser85Arg)	LOC106804613|HBA1	S85R	not provided	Likely benign(Last reviewed: Dec 23, 2021)	criteria provided, single submitter	VCV001679446	16	227087	16	177088	1679446	1671366		NC_000016.10:177087:C:A
NM_000558.5(HBA1):c.62A>C (p.His21Pro)	LOC106804613|HBA1	H21P	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2021)	criteria provided, conflicting interpretations	VCV001330135	16	226777	16	176778	1330135	1320817		NC_000016.10:176777:A:C
NM_000558.5(HBA1):c.150C>A (p.Ser50Arg)	LOC106804613|HBA1	S50R	not provided	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000993349	16	226982	16	176983	993349	981945	rs1318437795	NC_000016.10:176982:C:A
NM_000558.5(HBA1):c.358C>T (p.Pro120Ser)	LOC106804613|HBA1	P120S	Heinz body anemia|Methemoglobinemia, alpha type|Hemoglobin H disease|Erythrocytosis, familial, 7|alpha Thalassemia|not specified|not provided|alpha Thalassemia	Pathogenic(Last reviewed: Nov 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000811900	16	227339	16	177340	811900	799854	rs63750751	NC_000016.10:177339:C:T
NM_000558.5(HBA1):c.207C>G (p.Asn69Lys)	LOC106804613|HBA1	N69K	not provided	Likely benign(Last reviewed: Oct 24, 2022)	criteria provided, multiple submitters, no conflicts	VCV000439095	16	227039	16	177040	439095	432867	rs1060339	NC_000016.10:177039:C:G
NM_000558.3(HBA1):c.11C>T (p.Ser4Phe)	LOC106804613|HBA1	S4F	HEMOGLOBIN DOUALA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015878	16	226726	16	176727	15878	30917	rs35850071	NC_000016.10:176726:C:T
NM_000558.3(HBA1):c.166G>C (p.Val56Leu)	LOC106804613|HBA1	V56L	HEMOGLOBIN ROUBAIX	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015877	16	226998	16	176999	15877	30916	rs34068598	NC_000016.10:176998:G:C
NM_000558.3(HBA1):c.238G>A (p.Ala80Thr)	LOC106804613|HBA1	A80T	HEMOGLOBIN MANTES-LA-JOLIE	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015867	16	227070	16	177071	15867	30906	rs34586189	NC_000016.10:177070:G:A
NM_000558.3(HBA1):c.74A>G (p.Tyr25Cys)	LOC106804613|HBA1	Y25C	HEMOGLOBIN RAMONA	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015860	16	226789	16	176790	15860	30899	rs28928880	NC_000016.10:176789:A:G
NM_000558.3(HBA1):c.179G>A (p.Gly60Asp)	LOC106804613|HBA1	G60D	not provided	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015849	16	227011	16	177012	15849	30888	rs28928878	NC_000016.10:177011:G:A
NM_000558.3(HBA1):c.331G>A (p.Ala111Thr)	LOC106804613|HBA1	A111T	HEMOGLOBIN TONOSHO	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015838	16	227312	16	177313	15838	30877	rs34629158	NC_000016.10:177312:G:A
NM_000558.5(HBA1):c.104T>G (p.Leu35Arg)	LOC106804613|HBA1	L35R	not provided	Uncertain significance(Last reviewed: Nov 16, 2022)	criteria provided, multiple submitters, no conflicts	VCV000015795	16	226936	16	176937	15795	30834	rs35203445	NC_000016.10:176936:T:G
NM_000558.5(HBA1):c.262C>T (p.His88Tyr)	LOC106804613|HBA1	H88Y	HEMOGLOBIN M (KANKAKEE)|HEMOGLOBIN M (OLDENBURG)|HEMOGLOBIN M (SENDAI)|HEMOGLOBIN M (IWATE)	Pathogenic	no assertion criteria provided	VCV000015779	16	227094	16	177095	15779	30818	rs28928876	NC_000016.10:177094:C:T
NM_000558.3(HBA1):c.[235A>G;239C>G]	HBA1|LOC106804613	N79D, A80G	HEMOGLOBIN J (SINGAPORE)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015762	16|16	227067	16|16	177068	15762	30800|38474	rs33964623|rs387906544	NC_000016.10:177067:A:G|NC_000016.10:177071:C:G
NM_000558.5(HBA1):c.235A>G (p.Asn79Asp)	LOC106804613|HBA1	N79D	HEMOGLOBIN J (SINGA)	other(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000015761	16	227067	16	177068	15761	30800	rs33964623	NC_000016.10:177067:A:G
NM_000558.3(HBA1):c.287C>T (p.Pro96Leu)	LOC106804613|HBA1	P96L	not specified	Likely pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000015730	16	227119	16	177120	15730	30769	rs33931314	NC_000016.10:177119:C:T
